Best of July: Top 5 Insights In Clinical Trial Technology

#1 - Correct But Misleading: AI Hallucinations In Complex Decision-Making

Managing risks associated with AI hallucinations requires "explainability," a process that identifies patterns or behaviors in AI models that are inconsistent with training data or logical expectations.Learn more about how hallucinations manifest in AI systems.

#2 - Four Top 20 Biopharmas Share Why They've Switched To Veeva Clinical Data

Learn why four top biopharmas made the switch to Vault EDC. Companies making the switch are achieving 50% faster builds and 30-50% less data cleaning effort and costs.

#3 - Could GenAI Dramatically Reduce The Cost Of Regulatory Medical Writing?

Explore how time-poor regulatory professionals stand to benefit substantially from generative AI, which can speed up the creation of marketing authorization applications or life cycle maintenance activities, for example. 

#4 - eCOA Solution Design Recommendations: Applied Insights From Trial Sites, CRAs

Enhance hybrid trials with digitalization through remote data capture using smartphones, tablets, and computers, improving participant experience and data integrity.

#5 - Meaningful Industry Change Means Balancing Tech And Human Touch

Technology and AI/ML are advancing at an unprecedented pace, and we must not lose sight of our industry's core: human-to-human interaction.